Webinars

HTML

On-Demand Webinars
and Subscriptions

A Knowledge Base for Your Clinical Lab

  • Learn from Industry Experts

    Bio-Rad understands the importance of education. That's why we've partnered with experts to create an online educational library where you can browse, learn and stay relevant in your area of testing.

Check Out Our Featured Webinars

transfusion science webinar image

IMMUNOHEMATOLOGY

Hemolytic Disease of the Fetus and Newborn (HDFN)

Carla Dinardo, MD, PhD, explains why the Hemolytic Disease of the Fetus and Newborn (HDFN) remains a challenge despite the many advances made to either prevent, or diagnose and treat HDFN and its complications.

Watch webinar

sars-cov-2 webinar image

COVID-19

What Can SARS-CoV-2 Serology Testing Tell Us About Immune Status?

Two years into the global COVID-19 pandemic, the role of serology testing to evaluate immune responses has not yet been defined. This webinar will explore the role of serology testing to assess immune status.

Watch webinar

diabetes webinar image

DIABETES & HEMOGLOBINOPATHIES

The Strengths and Weaknesses of HbA1c in the Diagnosis of Diabetes

Dave Koch, PhD, DABCC, covers the strengths, weaknesses and practical details of HbA1c in the diagnosis of diabetes. This includes how HbA1c is useful in diagnosing and monitoring diabetes and how hemoglobin variants in the patient sample and other patient characteristics might impact the HbA1c result that is obtained.

Watch webinar

  • user friendly icon

    Transfusion Science Webinars

    Our Transfusion Science Webinars connect international experts in transfusion sciences to our Immunohematology community through educational content addressing hemolytic anemia, issues in ABO antibody titration, electronic issue in blood transfusion, and more. View our latest webinar or presentations on demand.

    Access on-demand webinars

  • transfusion science webinar

Browse Webinars by Category

Bio-Rad offers a host of webinars to keep your laboratory current. Peruse our library below. All webinars are presented in English unless noted otherwise.

Infectious Disease

SARS-CoV-2 / COVID-19

  • What Can SARS-CoV-2 Serology Testing Tell Us About Immune Status?
    Two years into the global COVID-19 pandemic, the role of serology testing to evaluate immune responses has not yet been defined. This webinar will explore the role of serology testing to assess immune status. This includes understanding how SARS-CoV-2 serology testing results correlate with individual immune responses to COVID-19 infections or vaccinations, and the value of SARS-CoV-2 serology testing and potential role of quantitative assays in determining protection against COVID-19. This webinar will also review serological responses from SARS-CoV-2 variants with a new quantitative assay that can differentiate multiple neutralizing and binding antibodies within a single test.
  • Making the Choice – Serology Assays in COVID-19 Diagnostics and Surveillance
    It has been suggested that combining serological diagnostic testing with molecular testing may be useful in confirming COVID-19 infection or exposure to the virus. This webinar will look at the role of serology tests in the pandemic response, the clinical value of a Total Ab assay, and the actual performance and clinical utility of Platelia SARS CoV-2 Total Ab Assay for the COVID-19 pandemic response. Presented by Jean-François Mouscadet.

COVID-19 Associated Pulmonary Aspergillosis (CAPA)

  • How Can Galactomannan Detection Improve CAPA Diagnosis?
    In this on-demand webinar, Pr Denning presents interesting data related to a retrospective multicenter review performed in France in 2020. For patients admitted to the ICU with positive SARS-CoV-2 qPCR, most included in this study were mechanically ventilated during their hospital stay. For patients whose clinical picture worsened, some may have had a blood and/or bronchoalveolar lavage sample taken for galactomannan detection, BDG, or PCR testing. In the case of a positive result, the patient was considered as having a probable underlying Invasive Pulmonary Aspergillosis (IPA). For patients classified within the “IPA” group, the mortality was significantly higher than patients classified within the “no IPA” group (71% mortality vs 37%).2
  • COVID-19 Associated Pulmonary Aspergillosis (CAPA): Definition, Diagnosis, and Treatment
    In this on-demand webinar, Dr. Philipp Köhler presents the different diagnostic procedures that can be routinely used to diagnose CAPA. Dr. Köhler presents about the CAPA incidence during 2020 in many countries and notes that the incidence is higher with mechanical ventilation.3 He references the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.4
  • COVID-19 Expertise
    More recently, Bio-Rad has provided a wide range of products for use in the support of COVID-19 diagnostic screening, confirmation of test results, surveillance, and therapy/vaccine research and development. From virus detection using real-time PCR, Droplet Digital PCR or Ag Rapid Test Assay, to immunology assays, our wide range of solutions provide best-in-class sensitivity and accuracy. Learn more.
  • Bio-Rad Mycology & COVID-19 Solution
    In order to fight against COVID-19 and to offer better management of patients, Bio-Rad, since the beginning of 2020, has continued to expand its offer with a complete range of reagents, instruments, and quality controls. Bio-Rad’s first assay was the Platelia SARS-CoV-2 Total Ab test, introduced in April 2020. To learn more about the Bio-Rad microplate solution related to invasive fungal infections and SARS-CoV-2, please view the following video.

References

  1. Borman AM et al. (2020). COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory. J Clin Microbiol. 59(1):e02136-20. doi:10.1128/JCM.02136-20.
  2. Dellière S et al. (2020). Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort [published online ahead of print, 2020 Dec 13]. Clin Microbiol Infect. 27(5):790.e1-790.e5. doi:10.1016/j.cmi.2020.12.005.
  3. Salmanton-García J et al. (2021). COVID-19-Associated Pulmonary Aspergillosis, March-August 2020. Emerg Infect Dis. 27(4):1077-1086. doi:10.3201/eid2704.204895.
  4. Koehler P et al. (2021). Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 21(6):e149-e162. doi:10.1016/S1473-3099(20)30847-1.

Immunohematology

Transfusion Science Webinars

Diabetes / Hemoglobinopathies

HbA1c

Hemoglobinopathies

Quality Control

InteliQ

Molecular QC

Serum Indices